Royalty Pharma
RPRX
$27.41
Share price
3.87%
Change (1 day)
-17.37%
Change (1 year)
Categories
Royalty Pharma (RPRX) - P/B ratio
P/B ratio as of June 2024 : 1.60
According to Royalty Pharma's latest financial reports the company has a price-to-book ratio of 1.60.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Royalty Pharma - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.67 | -8.74% |
| 2022-12-31 | 1.83 | 9.58% |
| 2021-12-31 | 1.67 | -14.92% |
| 2020-12-31 | 1.96 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.53 | 183.50% | 🇺🇸 USA |
 Eli Lilly LLY | 60.1 | 3,656.12% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | 2.79 | 74.47% | 🇺🇸 USA |